EP2510902A1 — Intraocular injection device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-10-17 · 14y expired
What this patent protects
Described is a device for intraocular injection comprising a drug delivery device, a foot (5) at a distal end of the drug delivery device for positioning the drug delivery device with respect to an injection site, and a magnifying device (8) coupled to one of the drug delivery de…
USPTO Abstract
Described is a device for intraocular injection comprising a drug delivery device, a foot (5) at a distal end of the drug delivery device for positioning the drug delivery device with respect to an injection site, and a magnifying device (8) coupled to one of the drug delivery device and the foot for magnifying a view of the injection site.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.